Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 21.77% is 267% above its 5-year average of -13.06%, near the high end of its 5-year range (-48.39%–21.77%).
As of the fiscal period ended Tuesday, June 30, 2026. 29.13% above its 12-month average of 16.86%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 21.77%.
RETURN ON INVESTED CAPITAL (ROIC)
21.77%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
16.86%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-0.04%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-13.06%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-26.04%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-28.01%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-40.55%
CURRENT VS TTM AVG
+29.13%
CURRENT VS 3Y AVG
+58442.52%
CURRENT VS 5Y AVG
+266.68%
CURRENT VS 10Y AVG
+183.61%
CURRENT VS 15Y AVG
+177.73%
CURRENT VS 20Y AVG
+153.69%
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 826 covered companies
CURRENT VS SECTOR MEDIAN
+161.08%
vs the sector median at left
Aurinia Pharmaceuticals Inc.
Market Cap
$2.02B
Return on Invested Capital (ROIC)
21.77%
TTM Avg
16.86%
3Y Avg
-0.04%
5Y Avg
-13.06%
Market Cap
$2.02B
Return on Invested Capital (ROIC)
-34.96%
TTM Avg
-60.72%
3Y Avg
-59.19%
5Y Avg
-76.26%
Market Cap
$2.03B
Return on Invested Capital (ROIC)
15.47%
TTM Avg
9.87%
3Y Avg
8.85%
5Y Avg
8.76%
Market Cap
$2.04B
Return on Invested Capital (ROIC)
-89.73%
TTM Avg
-14.48%
3Y Avg
-24.76%
5Y Avg
-41.39%
Market Cap
$2.04B
Return on Invested Capital (ROIC)
0.62%
TTM Avg
-3.84%
3Y Avg
-0.68%
5Y Avg
-0.08%
Market Cap
$2.05B
Return on Invested Capital (ROIC)
3.61%
TTM Avg
5.05%
3Y Avg
-22.39%
5Y Avg
-28.34%
Market Cap
$2.06B
Return on Invested Capital (ROIC)
-39.18%
TTM Avg
-43.45%
3Y Avg
-43.80%
5Y Avg
-51.45%
Market Cap
$2.06B
Return on Invested Capital (ROIC)
-45.19%
TTM Avg
-39.97%
3Y Avg
-37.50%
5Y Avg
-32.54%
Market Cap
$1.98B
Return on Invested Capital (ROIC)
6.33%
TTM Avg
5.44%
3Y Avg
-1.33%
5Y Avg
-7.01%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.02B | 21.77% | 16.86% | -0.04% | -13.06% |
| UroGen Pharma Ltd. (URGN)vs › | $2.02B | -34.96% | -60.72% | -59.19% | -76.26% |
| Progyny, Inc. (PGNY)vs › | $2.03B | 15.47% | 9.87% | 8.85% | 8.76% |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.04B | -89.73% | -14.48% | -24.76% | -41.39% |
| Fortrea Holdings Inc. (FTRE)vs › | $2.04B | 0.62% | -3.84% | -0.68% | -0.08% |
| Alvotech (ALVO)vs › | $2.05B | 3.61% | 5.05% | -22.39% | -28.34% |
| Viridian Therapeutics, Inc. (VRDN)vs › | $2.06B | -39.18% | -43.45% | -43.80% | -51.45% |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.06B | -45.19% | -39.97% | -37.50% | -32.54% |
| Inspire Medical Systems, Inc. (INSP)vs › | $1.98B | 6.33% | 5.44% | -1.33% | -7.01% |
| Vera Therapeutics, Inc. (VERA)vs › | $2.07B | -85.78% | -36.41% | -56.32% | -60.45% |
ROIC
21.8%
ROE
51.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 21.77% |
| 2026-03-31 | 19.53% |
| 2025-12-31 | 15.95% |
| 2025-09-30 | 15.16% |
| 2025-06-30 | 11.89% |
| 2025-03-31 | 6.64% |
| 2024-12-31 | -0.36% |
| 2024-09-30 | -6.40% |
| 2024-06-30 | -13.02% |
| 2024-03-31 | -16.34% |
| 2023-12-31 | -19.47% |
| 2023-09-30 | -18.73% |
| 2023-06-30 | -17.11% |
| 2023-03-31 | -25.18% |
| 2022-12-31 | -26.24% |
| 2022-09-30 | -26.00% |
| 2022-06-30 | -35.07% |
| 2022-03-31 | -35.53% |
| 2021-12-31 | -35.95% |
| 2021-09-30 | -48.39% |
| 2021-06-30 | -41.47% |
| 2021-03-31 | -32.27% |
| 2020-12-31 | -24.16% |
| 2020-09-30 | -26.75% |
| 2020-06-30 | -35.53% |
| 2020-03-31 | -29.40% |
| 2019-12-31 | -24.36% |
| 2019-09-30 | -50.98% |
| 2019-06-30 | -41.76% |
| 2019-03-31 | -36.71% |
| 2018-12-31 | -40.52% |
| 2018-09-30 | -35.56% |
| 2018-06-30 | -32.75% |
| 2018-03-31 | -28.65% |
| 2017-12-31 | -25.90% |
| 2017-09-30 | -22.26% |
| 2017-06-30 | -16.92% |
| 2017-03-31 | -13.74% |
| 2016-12-31 | -46.50% |
| 2016-09-30 | -71.31% |
| 2016-06-30 | -81.29% |
| 2016-03-31 | -94.79% |
| 2015-12-31 | -78.73% |
| 2015-09-30 | -65.46% |
| 2015-06-30 | -50.86% |
| 2015-03-31 | -42.08% |
| 2014-12-31 | -35.00% |
| 2014-09-30 | -25.77% |
| 2014-06-30 | -19.22% |
| 2014-03-31 | -11.89% |
| 2013-12-31 | -22.19% |
| 2013-09-30 | -63.15% |
| 2012-09-30 | -38.16% |
| 2012-06-30 | -18.39% |
| 2012-03-31 | -7.09% |
| 2011-12-31 | -54.58% |
| 2011-09-30 | -37.19% |
| 2011-06-30 | -41.87% |
| 2011-03-31 | -47.79% |
| 2010-12-31 | -56.43% |
| 2010-09-30 | -48.03% |
| 2010-06-30 | -76.71% |
| 2010-03-31 | -92.65% |
| 2009-12-31 | -132.79% |
| 2009-09-30 | -117.41% |
| 2009-06-30 | -134.38% |
| 2009-03-31 | -148.21% |
| 2008-12-31 | -75.02% |
| 2008-09-30 | -85.90% |
| 2008-06-30 | -82.41% |
| 2008-03-31 | -123.22% |
| 2007-12-31 | -105.13% |
| 2007-09-30 | -75.43% |
| 2007-06-30 | -64.67% |
| 2007-03-31 | -50.81% |
| 2006-12-31 | -93.86% |
| 2006-09-30 | -81.31% |
| 2006-06-30 | -66.50% |
| 2006-03-31 | -65.17% |
| 2005-12-31 | -63.56% |
| 2005-09-30 | -51.48% |
| 2005-06-30 | -68.12% |
| 2005-03-31 | -52.69% |
| 2004-12-31 | -39.76% |
| 2004-09-30 | -31.39% |
| 2004-06-30 | -27.35% |
| 2004-03-31 | -16.91% |
| 2003-12-31 | -15.77% |
| 2003-09-30 | -12.01% |
| 2003-06-30 | -4.47% |
